Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 12Genitourinary 3Other hematologic neoplasm 2CNS 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Myeloid 1Lymphoid 1Breast 1

Conditions

Neoplasms by Site 1Neoplasm Metastasis 1

Interventions

Gemcitabine 26Paclitaxel 24pembrolizumab 23Carboplatin 22Bevacizumab 18Radiotherapy 16Oxaliplatin 16Erlotinib Hydrochloride 16Nivolumab 15Cisplatin 14Capecitabine 14Fluorouracil 13Trastuzumab 12Docetaxel 12atezolizumab 11Magnetic Resonance Spectroscopy 11Leucovorin 11Cyclophosphamide 11Irinotecan 10Ipilimumab 10Vemurafenib 9Everolimus 9Cetuximab 9cabozantinib 8Radiosurgery 8Afatinib 8130-nm albumin-bound paclitaxel 8trametinib 7lenvatinib 7durvalumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × montanide ISA 51 × Tumor-Agnostic × Clear all
NCT03003195 2024-09-03

The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients

University of Arkansas

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡